Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Amikacin by PureIMS for Tuberculosis: Likelihood of Approval
Amikacin is under clinical development by PureIMS and currently in Phase I for Tuberculosis. According to GlobalData, Phase I drugs...